India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration
Aesthetics Advisor
FEBRUARY 9, 2024
The training provided by NCI scientists—including Nirali Shah, M.D., The visit helped guide Dr. ImmunoACT, a spin-off company of IIT Bombay, funded the trial and will be manufacturing actalycabtagene autoleucel and bringing it to market. million in 2023, up from about 980,000 in 2010. Dwivedi (who earned her Ph.D.
Let's personalize your content